Henry “Hank” Hrdlicka, PhD
Director of Research, Milne Institute for Healthcare Innovation
PhD, Biomedical Sciences, University of Connecticut at UConn Health, 2020
BS, Biochemistry and Molecular Biology, Nebraska Wesleyan University, 2014
Henry C. Hrdlicka, PhD, is the Director of Research at Gaylord Specialty Healthcare’s Milne Institute for Healthcare Innovation Center for Research and Innovation. In this role, Dr. Hrdlicka is directing the research activities of the Milne Institute to advance its goals of establishing evidence based clinical practice guidelines to further improve patient outcomes and developing scientific and therapeutic breakthroughs. To accomplish this, Dr. Hrdlicka works with clinical investigators across the Gaylord Specialty Healthcare System to develop innovative, pragmatic, and multidisciplinary work with clinicians and other leaders in healthcare and academia.
Before joining Gaylord Specialty Healthcare in September 2020, Dr. Hrdlicka completed his PhD research in Biomedical Sciences at the University of Connecticut at UConn Health, in Farmington Connecticut. There he studied the role of the microRNA-29 family in osteoclast and osteoblast biology. Prior to this position, Dr. Hrdlicka served as one of the Milne Institute’s Research Coordinators.
Contribution to Science
Research in progress includes:
- Evaluating the impact of research education on clinical staff participation and interest in research.
- Reducing institutional falls through implementation of a continuous visual monitoring system.
- Validity and Reliability testing of a novel inpatient occupational therapy cognitive screen.
- Gaidos S, Hrdlicka HC, Corbett J. Implementation of a Free Water Protocol at a Long Term Acute Care Hospital. In-press. Scientific Reports. Anticipated Feb 23, 2023. doi: 10.1038/s41598-023-29448-5.
- Meyer A, Hrdlicka HC, Cutler E, Hellstrand J, Meise E, Rudolf K, Grevelding P, Nankin M. A Novel Body Weight-Supported Postural Perturbation Module for Gait and Balance Rehabilitation After Stroke: Preliminary Evaluation Study. JMIR Rehabil Assist Technol. 2022 Mar 1;9(1):e31504. doi: 10.2196/31504. PMID: 35080495; PMCID: PMC8924779.
- Connors C, McNeill S, Hrdlicka HC. Occupational and Physical Therapy Strategies for the Rehabilitation of COVID-19-Related Guillain-Barré Syndrome in the Long-term Acute Care Hospital Setting: Case Report. JMIR Rehabil Assist Technol. 2022 Feb 10;9(1):e30794. doi: 10.2196/30794. PMID: 35023838; PMCID: PMC8834873.
- Grevelding P, Hrdlicka HC, Holland S, Cullen L, Meyer A, Connors C, Cooper D, Greco A. Patient Outcomes and Lessons Learned From Treating Patients With Severe COVID-19 at a Long-term Acute Care Hospital: Single-Center Retrospective Study. JMIR Rehabil Assist Technol. 2022 Feb 10;9(1):e31502. doi: 10.2196/31502. PMID: 35023835; PMCID: PMC8834875.
- Hrdlicka HC, Pereira RC, Shin B, Yee SP, Deymier AC, Lee SK, Delany AM. Inhibition of miR-29-3p isoforms via tough decoy suppresses osteoblast function in homeostasis but promotes intermittent parathyroid hormone-induced bone anabolism. Bone. 2021 Feb;143:115779. doi: 10.1016/j.bone.2020.115779. Epub 2020 Nov 28. PMID: 33253931; PMCID: PMC7770763.
Dr. Hrdlicka has also presented his works at several state and national conferences.